RNA interference screen to identify new targets for therapeutic intervention in B-cell lymphoma
Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma.
Leuk Lymphoma 2015 Jun;56(6):1742-9. Epub 2014 nov 19
Artesunate shows potent anti-tumor activity in B-cell lymphoma
Journal of Hematology & Oncology (in press 2018)